Literature DB >> 34823736

Understanding Stimulant Use and Use Disorders in a New Era.

Daniel Ciccarone1, Steve Shoptaw2.   

Abstract

Extending from the triple wave epidemic of opioid-related overdose deaths, a fourth wave of high mortality involving methamphetamine and cocaine use has been gathering force. This article provides a review of the published literature on stimulants including epidemiology, pharmacology, neurobiology, medical and psychiatric consequences, withdrawal management, and medical and behavioral treatments.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavioral treatments; Cocaine; Epidemiology; Fentanyl; Medication treatments; Methamphetamine; Neurobiology; Pharmacology

Mesh：

Substances：

Year:  2022        PMID： 34823736      PMCID： PMC8670631          DOI： 10.1016/j.mcna.2021.08.010

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  85 in total

1.  Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Authors:  Grant N Colfax; Glenn-Milo Santos; Moupali Das; Deirdre McDermott Santos; Tim Matheson; James Gasper; Steve Shoptaw; Eric Vittinghoff
Journal:  Arch Gen Psychiatry       Date:  2011-11

Review 2.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  International snapshot of new psychoactive substance use: Case study of eight countries over the 2019/2020 new year period.

Authors:  Richard Bade; Jason M White; Jingjing Chen; Jose Antonio Baz-Lomba; Frederic Been; Lubertus Bijlsma; Daniel A Burgard; Sara Castiglioni; Noelia Salgueiro-Gonzalez; Alberto Celma; Andrew Chappell; Erik Emke; Ruud Steenbeek; Degao Wang; Ettore Zuccato; Cobus Gerber
Journal:  Water Res       Date:  2021-02-03       Impact factor: 11.236

Review 4.  Synthetic cathinones: an evolving class of new psychoactive substances.

Authors:  João L Gonçalves; Vera L Alves; Joselin Aguiar; Helena M Teixeira; José S Câmara
Journal:  Crit Rev Toxicol       Date:  2019-11-20       Impact factor: 5.635

Review 5.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Authors:  Daniel Ciccarone
Journal:  Prim Care       Date:  2011-01-11       Impact factor: 2.907

6.  Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

Authors:  Diana Martinez; Kenneth M Carpenter; Fei Liu; Mark Slifstein; Allegra Broft; Alessandra Calvo Friedman; Dileep Kumar; Ronald Van Heertum; Herbert D Kleber; Edward Nunes
Journal:  Am J Psychiatry       Date:  2011-03-15       Impact factor: 18.112

Review 7.  Disulfiram for the treatment of cocaine dependence.

Authors:  Pier Paolo Pani; Emanuela Trogu; Rosangela Vacca; Laura Amato; Simona Vecchi; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids.

Authors:  Justin C Strickland; Jennifer R Havens; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2019-09-27       Impact factor: 4.492

9.  Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus.

Authors:  Jennifer A Fulcher; Steven Shoptaw; Solomon B Makgoeng; Julie Elliott; F Javier Ibarrondo; Amy Ragsdale; Ron Brookmeyer; Peter A Anton; Pamina M Gorbach
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

10.  Fishbowls and candy bars: using low-cost incentives to increase treatment retention.

Authors:  Nancy M Petry; Michael J Bohn
Journal:  Sci Pract Perspect       Date:  2003-08
View more
  1 in total

Review 1.  Addressing adolescent substance use with a public health prevention framework: the case for harm reduction.

Authors:  James Michael Winer; Amy M Yule; Scott E Hadland; Sarah M Bagley
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.